Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode
Clinical trial NCT00216671 · COMPLETED
Trial details
- NCT number
- NCT00216671
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2009-12-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.